Michael Medici Named to Growth Cap's Top 25 Software Investors of 2022

Michael Medici, a Managing Director on Summit’s technology team, has been named to GrowthCap’s Top 25 Software Investors of 2022. This award recognizes some of the most experienced and accomplished individuals in software investing. Since joining the firm in 2005, Michael has invested in and partnered with numerous high-growth companies across the technology landscape, building deep sector expertise within several software subsectors, including commerce enablement, marketing automation, infrastructure and DevOps, industrial technology and supply chain.

Michael is currently a board director at Klaviyo, MacStadium, Markforged (NYSE: MKFG), Mavrck and Sifted. His prior board and investment experience includes Acacia Communications (NASDAQ: ACIA, later acquired by Cisco), Accedian Networks (acquired by Bridge Growth Partners), Anesthetix (acquired by TeamHealth), Clarabridge (acquired by Qualtrics), Diagnostic Hybrids (acquired by Quidel Corporation), Fermentas International (acquired by Thermo Fisher Scientific), Hiperos (acquired by Opus Global), Logi Analytics (acquired by Marlin Equity Partners), Mi9 Retail (acquired by General Atlantic), and Telerik (acquired by Progress Software).

Read more about Michael and his fellow honorees here.